DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1Dr.Reddy's laboratories Limited
02 1COPRIMA SL
03 1Moehs Catalana SL
04 1AURORE PHARMACEUTICALS PRIVATE LIMITED
05 1Aurobindo Pharma Limited
06 1CTX Lifesciences Pvt. Ltd.
07 1Cadila Pharmaceuticals Limited
08 1Cipla Ltd.
09 1Divi's Laboratories Limited
10 1Ipca Laboratories Limited
11 1Raks Pharma Pvt. Limited
12 1SHODHANA LABORATORIES PRIVATE LIMITED
13 1Symed Labs Limited
14 1Tianish Laboratories Private Limited
15 1ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD.
16 1Zydus Lifesciences Limited
01 4CARVEDILOL
02 12Carvedilol
01 1China
02 13India
03 2Spain
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 55111-030
Start Marketing Date : 2002-12-23
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 52932-0726
Start Marketing Date : 2015-02-02
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 68294-0005
Start Marketing Date : 2013-04-05
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65691-0087
Start Marketing Date : 2014-04-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53104-7575
Start Marketing Date : 2016-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 42419-013
Start Marketing Date : 2012-04-14
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62331-036
Start Marketing Date : 2006-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 57451-1155
Start Marketing Date : 2012-04-02
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 47621-064
Start Marketing Date : 2020-09-14
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 64220-150
Start Marketing Date : 2005-12-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Carvedilol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Carvedilol, including repackagers and relabelers. The FDA regulates Carvedilol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Carvedilol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Carvedilol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Carvedilol supplier is an individual or a company that provides Carvedilol active pharmaceutical ingredient (API) or Carvedilol finished formulations upon request. The Carvedilol suppliers may include Carvedilol API manufacturers, exporters, distributors and traders.
click here to find a list of Carvedilol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Carvedilol as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Carvedilol API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Carvedilol as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Carvedilol and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Carvedilol NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Carvedilol suppliers with NDC on PharmaCompass.
We have 15 companies offering Carvedilol
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?